Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 2
1994 1
1995 3
1996 3
1997 2
1998 5
1999 22
2000 26
2001 33
2002 44
2003 57
2004 58
2005 101
2006 83
2007 115
2008 181
2009 208
2010 215
2011 186
2012 222
2013 203
2014 188
2015 157
2016 138
2017 125
2018 134
2019 134
2020 144
2021 149
2022 130
2023 118
2024 151
2025 146
2026 47

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,123 results

Results by year

Filters applied: . Clear all
Page 1
Effects of telmisartan on metabolic syndrome components: a comprehensive review.
Imenshahidi M, Roohbakhsh A, Hosseinzadeh H. Imenshahidi M, et al. Biomed Pharmacother. 2024 Feb;171:116169. doi: 10.1016/j.biopha.2024.116169. Epub 2024 Jan 15. Biomed Pharmacother. 2024. PMID: 38228033 Free article. Review.
Moreover, telmisartan has an agonist activity on PPARalpha and PPARdelta receptors and modulates the adipokine levels. ...This review will highlight the role of telmisartan in metabolic syndrome and the main mechanisms of action of telmisartan are discussed a …
Moreover, telmisartan has an agonist activity on PPARalpha and PPARdelta receptors and modulates the adipokine levels. ...This review …
Telmisartan.
McClellan KJ, Markham A. McClellan KJ, et al. Drugs. 1998 Dec;56(6):1039-44; discussion 1045-6. doi: 10.2165/00003495-199856060-00007. Drugs. 1998. PMID: 9878991 Review.
Oral telmisartan dose-dependently reduced blood pressure (BP) in various animal models of hypertension. ...Telmisartan had a tolerability profile similar to that of placebo in clinical studies....
Oral telmisartan dose-dependently reduced blood pressure (BP) in various animal models of hypertension. ...Telmisartan had a t …
Telmisartan and cardioprotection.
Akhrass PR, McFarlane SI. Akhrass PR, et al. Vasc Health Risk Manag. 2011;7:677-83. doi: 10.2147/VHRM.S9447. Epub 2011 Nov 15. Vasc Health Risk Manag. 2011. PMID: 22140319 Free PMC article. Review.
The angiotensin receptor blockers' (ARBs) efficacy in lowering blood pressure has been very well established. Telmisartan is however the first ARB to show a promising role in reducing cardiovascular risk in high-risk patients. This article will highlight the role of tel …
The angiotensin receptor blockers' (ARBs) efficacy in lowering blood pressure has been very well established. Telmisartan is however …
The application of telmisartan in central nervous system disorders.
Quan W, Zhang SX, Zhang XY, Chen X, Yang C, Li ZY, Hu R. Quan W, et al. Pharmacol Rep. 2025 Oct;77(5):1196-1216. doi: 10.1007/s43440-025-00737-2. Epub 2025 Jun 19. Pharmacol Rep. 2025. PMID: 40536710 Free PMC article. Review.
Telmisartan, a well-established antihypertensive drug, has shown promising therapeutic potential for a variety of central nervous system (CNS) disorders. ...This review underscores the potential of telmisartan as a valuable therapeutic option for CNS disorders, warr …
Telmisartan, a well-established antihypertensive drug, has shown promising therapeutic potential for a variety of central nervous sys …
Telmisartan reverses hepatic steatosis via PCK1 upregulation: A novel PPAR-independent mechanism in experimental models of MASLD.
Bentanachs R, Ramírez-Carrasco P, Braster B, Emmanouilidou A, Mujica E, Rodrigo-Calvo M, Rodríguez C, Roglans N, den Hoed M, Laguna JC, Alegret M. Bentanachs R, et al. Pharmacol Res. 2025 Aug;218:107860. doi: 10.1016/j.phrs.2025.107860. Epub 2025 Jul 15. Pharmacol Res. 2025. PMID: 40675520 Free article.
Here, we have demonstrated that, in rats, both pemafibrate and telmisartan reverse hepatic steatosis induced by a high-fat, high-fructose diet. Pemafibrate attenuated liver steatosis via a PPARalpha-mediated increase in fatty acid catabolism, while the antisteatotic respon …
Here, we have demonstrated that, in rats, both pemafibrate and telmisartan reverse hepatic steatosis induced by a high-fat, high-fruc …
Single-pill combination therapy is the standard of care for hypertension, but it is time for the next step: Implementation.
Lopez-Lopez JP, Lopez-Jaramillo P. Lopez-Lopez JP, et al. Med. 2024 Dec 13;5(12):1461-1462. doi: 10.1016/j.medj.2024.11.010. Med. 2024. PMID: 39674172 Free article.
The GMRx2 trial(1) in adults with high blood pressure (BP) demonstrated that after 12 weeks, a low-dose single-pill combination of telmisartan, amlodipine, and indapamide significantly reduced BP levels compared to several dual combinations (telmisartan with amlodip …
The GMRx2 trial(1) in adults with high blood pressure (BP) demonstrated that after 12 weeks, a low-dose single-pill combination of telmis …
Telmisartan/amlodipine: single-pill combination in hypertension.
Moen MD. Moen MD. Am J Cardiovasc Drugs. 2010;10(6):401-12. doi: 10.2165/11204880-000000000-00000. Am J Cardiovasc Drugs. 2010. PMID: 21090832 Review.
Telmisartan/amlodipine is a single-pill combination of telmisartan, an angiotensin II receptor antagonist, and amlodipine, a dihydropyridine calcium channel antagonist, which is taken orally once daily for the treatment of hypertension. In the US and the EU, single- …
Telmisartan/amlodipine is a single-pill combination of telmisartan, an angiotensin II receptor antagonist, and amlodipine, a d …
Micardis/HCT (telmisartan/hydrochlorothiazide).
Scarpa WJ. Scarpa WJ. J Clin Hypertens (Greenwich). 2001 Jul-Aug;3(4):261. doi: 10.1111/j.1524-6175.2001.00471.x. J Clin Hypertens (Greenwich). 2001. PMID: 11498659 Free PMC article. No abstract available.
Antihypertensive effect of telmisartan versus perindopril in hypertensive patients.
Zhao D, Liu H, Chen S, Dong P. Zhao D, et al. Bratisl Lek Listy. 2023;124(5):380-386. doi: 10.4149/BLL_2023_058. Bratisl Lek Listy. 2023. PMID: 36876369
OBJECTIVE: We performed this meta-analysis determining the antihypertensive effect of telmisartan versus perindopril in patients with essential hypertension. BACKGROUND: The comparison of antihypertensive effects between telmisartan and perindopril were controversia …
OBJECTIVE: We performed this meta-analysis determining the antihypertensive effect of telmisartan versus perindopril in patients with …
3,123 results